 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              The Board of Directors of Venus Remedies Ltd in its meeting held today have allotted 9,00,000 Equity Shares of face value of Rs. 10 each at a price of Rs. 88.77 (Rupees Eighty Eight and seventy seven paise only) to promoters of the Company on conversion of fully convertible warrants on preferential basis.
Shares of VENUS REMEDIES LTD. was last trading in BSE at Rs.100.5 as compared to the previous close of Rs. 102.95. The total number of shares traded during the day was 16943 in over 263 trades.
The stock hit an intraday high of Rs. 103.25 and intraday low of 100.2. The net turnover during the day was Rs. 1715955.